Streamex Corp. Announces Name Change, Expands Business Model and Growth Strategy
ByAinvest
Wednesday, Sep 10, 2025 11:55 am ET1min read
BSGM--
The rebranding follows the recent merger with Streamex Exchange Corporation, a real-world asset (RWA) tokenization company. Streamex Exchange Corporation, now a wholly-owned subsidiary of BioSig Technologies, Inc., specializes in bringing the gold and commodities market onto the blockchain. This merger aims to leverage Streamex's advanced tokenization technology to modernize the commodities market .
The rebranding will not require shareholders to take any action, as the CUSIP number remains unchanged. Shareholders will continue to hold their stock under the new name and trading symbol, "STEX," which will commence trading on the Nasdaq Capital Market exchange on September 12, 2025. The corporate structure and operations will remain unchanged [1].
BioSig Technologies, Inc., now known as Streamex Corp., is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP™ Platform. This platform delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. The rebranding reflects the company's expansion into the RWA tokenization sector, marking a significant shift in its business focus .
The company has issued a press release detailing the rebranding and the merger, emphasizing the strategic importance of the move. The forward-looking statements in the press release highlight potential risks and uncertainties associated with the acquisition and compliance with Nasdaq's listing criteria [1].
Investors and financial professionals are encouraged to review the company's filings with the Securities and Exchange Commission for more detailed information, including the section titled "Risk Factors" in the Annual Report on Form 10-K, filed on April 15, 2025 [1].
References:
[1]: BioSig Technologies, Inc. (2025). BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp. Retrieved from [https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html](https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html)
: BioSig and Streamex. (2025). About Streamex Exchange Corporation. Retrieved from [https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html](https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html)
BioSig Technologies is rebranding to Streamex Corp., with a new ticker symbol "STEX", to focus on its expanded business model and growth strategy. The company has merged with Streamex Exchange Corporation, a real-world asset tokenization company, to bring the gold and commodities market on-chain. The rebranding is effective September 12, 2025, and all stock trading, filings, and market-related information will be reported under the new symbol.
BioSig Technologies, Inc. (NASDAQ: BSGM) has announced a significant corporate rebranding to Streamex Corp. The rebranding will take effect on September 12, 2025, and will be accompanied by a change in the company's ticker symbol to "STEX." This strategic move is part of the company's expanded business model and growth strategy [1].The rebranding follows the recent merger with Streamex Exchange Corporation, a real-world asset (RWA) tokenization company. Streamex Exchange Corporation, now a wholly-owned subsidiary of BioSig Technologies, Inc., specializes in bringing the gold and commodities market onto the blockchain. This merger aims to leverage Streamex's advanced tokenization technology to modernize the commodities market .
The rebranding will not require shareholders to take any action, as the CUSIP number remains unchanged. Shareholders will continue to hold their stock under the new name and trading symbol, "STEX," which will commence trading on the Nasdaq Capital Market exchange on September 12, 2025. The corporate structure and operations will remain unchanged [1].
BioSig Technologies, Inc., now known as Streamex Corp., is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP™ Platform. This platform delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. The rebranding reflects the company's expansion into the RWA tokenization sector, marking a significant shift in its business focus .
The company has issued a press release detailing the rebranding and the merger, emphasizing the strategic importance of the move. The forward-looking statements in the press release highlight potential risks and uncertainties associated with the acquisition and compliance with Nasdaq's listing criteria [1].
Investors and financial professionals are encouraged to review the company's filings with the Securities and Exchange Commission for more detailed information, including the section titled "Risk Factors" in the Annual Report on Form 10-K, filed on April 15, 2025 [1].
References:
[1]: BioSig Technologies, Inc. (2025). BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp. Retrieved from [https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html](https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html)
: BioSig and Streamex. (2025). About Streamex Exchange Corporation. Retrieved from [https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html](https://www.stocktitan.net/news/BSGM/bio-sig-technologies-inc-announces-corporate-rebrand-to-streamex-54btbccbi95c.html)

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet